A B Skotnicki

1.1k total citations
49 papers, 585 citations indexed

About

A B Skotnicki is a scholar working on Genetics, Pathology and Forensic Medicine and Hematology. According to data from OpenAlex, A B Skotnicki has authored 49 papers receiving a total of 585 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Genetics, 16 papers in Pathology and Forensic Medicine and 13 papers in Hematology. Recurrent topics in A B Skotnicki's work include Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). A B Skotnicki is often cited by papers focused on Chronic Lymphocytic Leukemia Research (16 papers), Lymphoma Diagnosis and Treatment (14 papers) and Immunodeficiency and Autoimmune Disorders (7 papers). A B Skotnicki collaborates with scholars based in Poland, United States and Czechia. A B Skotnicki's co-authors include Anna Dmoszyńska, Tadeusz Robak, Jerzy Hołowiecki, Marcelo B. Sztein, Marek Hus, Cheryl Samuels, Andrzej Hellmann, Wojciech Legieć, L Konopka and Goldstein Al and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and Journal of Clinical Oncology.

In The Last Decade

A B Skotnicki

45 papers receiving 564 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
A B Skotnicki Poland	14	252	211	146	138	132	49	585
Ilona Seferyńska Poland	15	374 1.5×	226 1.1×	94 0.6×	99 0.7×	189 1.4×	40	679
Elvira Deolinda Rodrigues Pereira Velloso Brazil	13	423 1.7×	209 1.0×	77 0.5×	70 0.5×	184 1.4×	81	654
Francis Lacombe France	14	287 1.1×	162 0.8×	141 1.0×	117 0.8×	190 1.4×	35	653
R. Hehlmann Germany	14	642 2.5×	495 2.3×	124 0.8×	55 0.4×	102 0.8×	28	887
Mette Østergaard Denmark	14	416 1.7×	112 0.5×	163 1.1×	58 0.4×	384 2.9×	29	843
Kentaro Yoshinaga Japan	13	130 0.5×	90 0.4×	70 0.5×	73 0.5×	67 0.5×	48	382
Luís Villela Mexico	12	152 0.6×	73 0.3×	139 1.0×	108 0.8×	94 0.7×	33	384
Chang Ki Min South Korea	11	177 0.7×	95 0.5×	163 1.1×	35 0.3×	125 0.9×	38	416
Takeyuki Sato Japan	14	264 1.0×	69 0.3×	70 0.5×	54 0.4×	260 2.0×	37	588
Jean‐Baptiste Micol France	18	726 2.9×	306 1.5×	140 1.0×	56 0.4×	452 3.4×	59	1.1k

Countries citing papers authored by A B Skotnicki

Since Specialization

Citations

This map shows the geographic impact of A B Skotnicki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A B Skotnicki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A B Skotnicki more than expected).

Fields of papers citing papers by A B Skotnicki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A B Skotnicki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A B Skotnicki. The network helps show where A B Skotnicki may publish in the future.

Co-authorship network of co-authors of A B Skotnicki

This figure shows the co-authorship network connecting the top 25 collaborators of A B Skotnicki. A scholar is included among the top collaborators of A B Skotnicki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A B Skotnicki. A B Skotnicki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Arcaini, Luca, Jan Walewski, A B Skotnicki, et al.. (2015). QUALITY OF LIFE IN RELAPSED/REFRACTORY MANTLE CELL LYMPHOMA PATIENTS TREATED WITH LENALIDOMIDE VS INVESTIGATOR'S CHOICE: MCL-002 (SPRINT) TRIAL. Haematologica. 2 indexed citations

Giraldo, Pilar, Francesca Palandri, Giuseppe A. Palumbo, et al.. (2015). SAFETY AND EFFICACY OF RUXOLITINIB (RUX) IN PATIENTS WITH INTERMEDIATE-1-RISK MYELOFIBROSIS (MF) FROM AN OPEN-LABEL, MULTICENTER, SINGLE-ARM EXPANDED-ACCESS STUDY. Haematologica. 100. 265–265. 5 indexed citations

Jurczak, Wojciech, Joanna Drozd‐Sokołowska, Piotr Boguradzki, et al.. (2011). High incidence of cardiovascular mortality caused by acute and early chronic progressive doxorubicin toxicity: Retrospective analysis of 606 patients.. Journal of Clinical Oncology. 29(15_suppl). e18532–e18532. 1 indexed citations

Giebel, Sebastian, Małgorzata Krawczyk‐Kuliś, Nicola Gökbuget, et al.. (2009). Status of minimal residual disease determines outcome of autologous hematopoietic SCT in adult ALL. Bone Marrow Transplantation. 45(6). 1095–1101. 39 indexed citations

Weigert, Oliver, Wojciech Jurczak, Agnieszka Giza, et al.. (2006). Efficacy of radioimmunotherapy with (⁹⁰Y) ibritumomab tiuxetan is superior as consolidation in relapsed or refractory mantle cell lymphoma: Results of two phase II trials of the European MCL Network and the PLRG. Journal of Clinical Oncology. 24(18_suppl). 7533–7533. 15 indexed citations

Dmoszyńska, Anna, Raouf Fetni, Cynthia A. Sirard, et al.. (2006). Cytogenetic correlation with efficacy on alemtuzumab (CAM) vs chlorambucil (CHLO) as front-line therapy for patients with progressive B-cell chronic lymphocytic leukemia (BCLL). Journal of Clinical Oncology. 24(18_suppl). 6601–6601. 3 indexed citations

Hołowiecki, Jerzy, Sebastian Grosicki, Maria Saduś‐Wojciechowska, et al.. (2005). Addition of Cladribine to Induction/Consolidation Regimen Does Not Impair Peripheral Blood Stem Cell Mobilization and Bone Marrow Harvest for Autotransplantation in Acute Myeloid Leukemia Patients. Transplantation Proceedings. 37(10). 4482–4487. 2 indexed citations

Kolarzyk, Emilia, et al.. (2005). Importance of Parenteral Nutrition in Patients Undergoing Hemopoietic Stem Cell Transplantation Procedures in the Autologous System. Journal of Parenteral and Enteral Nutrition. 29(4). 241–247. 13 indexed citations

Jurczak, Wojciech, Agnieszka Giza, Dorota Krochmalczyk, et al.. (2005). Consolidation of Chemotherapy Response in Mantle Cell Lymphoma (MCL) Patients with 90Y-Ibritumomab Tiuxetan (90Y-Zevalin) Radioimmunotherapy (RIT).. Blood. 106(11). 2453–2453. 3 indexed citations

10.

Hus, Iwona, Anna Dmoszyńska, Marek Hus, et al.. (2004). An evaluation of factors predicting long-term response to thalidomide in 234 patients with relapsed or resistant multiple myeloma. British Journal of Cancer. 91(11). 1873–1879. 9 indexed citations

11.

Robak, Tadeusz, Anna Szmigielska‐Kapłon, Agata Wrzesień‐Kuś, et al.. (2004). Acute lymphoblastic leukemia in elderly: the Polish Adult Leukemia Group (PALG) experience. Annals of Hematology. 83(4). 225–231. 22 indexed citations

12.

Wrzesień‐Kuś, Agata, Tadeusz Robak, Ewa Lech‐Marańda, et al.. (2003). A multicenter, open, non‐comparative, phase II study of the combination of cladribine (2‐chlorodeoxyadenosine), cytarabine, and G‐CSF as induction therapy in refractory acute myeloid leukemia – a report of the Polish Adult Leukemia Group (PALG). European Journal Of Haematology. 71(3). 155–162. 46 indexed citations

13.

Skotnicki, A B, et al.. (2003). 34. Wykorzystanie koncepcji fenomenologiczno – poznawczych w pracy klinicznej z pacjentami z chorobą nowotworową krwi. Reports of Practical Oncology & Radiotherapy. 8. S178–S178.

14.

Hus, Marek, Anna Dmoszyńska, Maria Soroka‐Wojtaszko, et al.. (2001). Thalidomide treatment of resistant or relapsed multiple myeloma patients.. PubMed. 86(4). 404–8. 78 indexed citations

15.

Robak, Tadeusz, Marek Kasznicki, Joanna Góra‐Tybor, et al.. (2001). Cladribine combined with cyclophosphamide and mitoxantrone as front-line therapy in chronic lymphocytic leukemia. Leukemia. 15(10). 1510–1516. 32 indexed citations

16.

Jablonski, Monica M., et al.. (1999). [Methods for freezing, thawing and viability estimation of hemopoietic stem cells].. PubMed. 56 Suppl 1. 34–9. 8 indexed citations

17.

Robak, Tadeusz, Maria Błasińska-Morawiec, E Krykowski, et al.. (1997). 2‐Chlorodeoxyadenosine (cladribine)‐related eosinophilia in patients with lymphoproliferative diseases. European Journal Of Haematology. 59(4). 216–220. 13 indexed citations

18.

Sztein, Marcelo B., Gary L. Simon, Rochelle Scheib, et al.. (1987). In vitro effects of thymosin and lithium on lymphoproliferative responses of normal donors and HIV seropositive male homosexuals with AIDS-related complex. Clinical Immunology and Immunopathology. 44(1). 51–62. 19 indexed citations

19.

Skotnicki, A B. (1985). [Effect of immunomodulators on the production of interleukin 2].. PubMed. 42(7). 573–9. 1 indexed citations

20.

Skotnicki, A B, et al.. (1981). [Various aspects of immunopathogenesis of multiple sclerosis and therapeutic possibilities].. PubMed. 36(35). 1363–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact